NSC-87877, inhibitor of SHP-1/2 PTPs, inhibits dual-specificity phosphatase 26 (DUSP26) - PubMed (original) (raw)

. 2009 Apr 17;381(4):491-5.

doi: 10.1016/j.bbrc.2009.02.069. Epub 2009 Feb 20.

Affiliations

• PMID: 19233143
• DOI: 10.1016/j.bbrc.2009.02.069

NSC-87877, inhibitor of SHP-1/2 PTPs, inhibits dual-specificity phosphatase 26 (DUSP26)

Mina Song et al. Biochem Biophys Res Commun. 2009.

Abstract

Protein phosphorylation plays critical roles in many regulatory mechanisms controlling cell activities and thus involved in various diseases. The cellular equilibrium of phosphorylation is regulated through the actions of protein kinases and phosphatases. Therefore, these regulatory proteins have emerged as promising targets for drug development. In this study, we screened protein tyrosine phosphatases (PTPs) by in vitro phosphatase assays to identify PTPs that are inhibited by 8-hydroxy-7-(6-sulfonaphthalen-2-yl)diazenyl-quinoline-5-sulfonic acid (NSC-87877), a potent inhibitor of SHP-1 and SHP-2 PTPs. Phosphatase activity of dual-specificity protein phosphatase 26 (DUSP26) was decreased by the inhibitor in a dose-dependent manner. Kinetic studies with NSC-87877 and DUSP26 revealed a competitive inhibition. NSC-87877 effectively inhibited DUSP26-mediated dephosphorylation of p38, a member of mitogen-activated protein kinase (MAPK) family. Since DUSP26 is involved in survival of anaplastic thyroid cancer (ATC) cells, NSC-87877 could be a therapeutic reagent for treating ATC.

PubMed Disclaimer

Similar articles

• NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis.
  Shi Y, Ma IT, Patel RH, Shang X, Chen Z, Zhao Y, Cheng J, Fan Y, Rojas Y, Barbieri E, Chen Z, Yu Y, Jin J, Kim ES, Shohet JM, Vasudevan SA, Yang J. Shi Y, et al. Cell Death Dis. 2015 Aug 6;6(8):e1841. doi: 10.1038/cddis.2015.207. Cell Death Dis. 2015. PMID: 26247726 Free PMC article.
• PTP inhibitor IV protects JNK kinase activity by inhibiting dual-specificity phosphatase 14 (DUSP14).
  Park JE, Park BC, Song M, Park SG, Lee DH, Park SY, Kim JH, Cho S. Park JE, et al. Biochem Biophys Res Commun. 2009 Oct 2;387(4):795-9. doi: 10.1016/j.bbrc.2009.07.127. Epub 2009 Jul 29. Biochem Biophys Res Commun. 2009. PMID: 19646420
• Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?
  Dempke WCM, Uciechowski P, Fenchel K, Chevassut T. Dempke WCM, et al. Oncology. 2018;95(5):257-269. doi: 10.1159/000490106. Epub 2018 Jun 20. Oncology. 2018. PMID: 29925063 Review.
• A Review of DUSP26: Structure, Regulation and Relevance in Human Disease.
  Thompson EM, Stoker AW. Thompson EM, et al. Int J Mol Sci. 2021 Jan 14;22(2):776. doi: 10.3390/ijms22020776. Int J Mol Sci. 2021. PMID: 33466673 Free PMC article. Review.

Cited by

• Analysis of the potential biological significance of glycosylation in triple-negative breast cancer on patient prognosis.
  Zhou H, Wang Z, Guo J, Zhu Z, Sun G. Zhou H, et al. Am J Transl Res. 2024 Jun 15;16(6):2212-2232. doi: 10.62347/PXAR3644. eCollection 2024. Am J Transl Res. 2024. PMID: 39006258 Free PMC article.
• Role of Non-Receptor-Type Tyrosine Phosphatases in Brain-Related Diseases.
  He Y, Nan D, Wang H. He Y, et al. Mol Neurobiol. 2023 Nov;60(11):6530-6541. doi: 10.1007/s12035-023-03487-5. Epub 2023 Jul 17. Mol Neurobiol. 2023. PMID: 37458988 Review.
• Paired immunoglobulin-like receptor B is an entry receptor for mammalian orthoreovirus.
  Shang P, Simpson JD, Taylor GM, Sutherland DM, Welsh OL, Aravamudhan P, Natividade RDS, Schwab K, Michel JJ, Poholek AC, Wu Y, Rajasundaram D, Koehler M, Alsteens D, Dermody TS. Shang P, et al. Nat Commun. 2023 May 5;14(1):2615. doi: 10.1038/s41467-023-38327-6. Nat Commun. 2023. PMID: 37147336 Free PMC article.
• Discovery of the SHP2 allosteric inhibitor 2-((3R,4R)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-5-(2,3-dichlorophenyl)-3-methylpyrrolo[2,1-f][1,2,4] triazin-4(3H)-one.
  Luo Y, Li J, Zong Y, Sun M, Zheng W, Zhu J, Liu L, Liu B. Luo Y, et al. J Enzyme Inhib Med Chem. 2023 Dec;38(1):398-404. doi: 10.1080/14756366.2022.2151594. J Enzyme Inhib Med Chem. 2023. PMID: 36476046 Free PMC article.
• The Discovery of Potent SHP2 Inhibitors with Anti-Proliferative Activity in Breast Cancer Cell Lines.
  Ghemrawi R, Khair M, Hasan S, Aldulaymi R, AlNeyadi SS, Atatreh N, Ghattas MA. Ghemrawi R, et al. Int J Mol Sci. 2022 Apr 18;23(8):4468. doi: 10.3390/ijms23084468. Int J Mol Sci. 2022. PMID: 35457286 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program